Subscribe to our Newsletters !!
Fermentation is a natural method which is applied
In the world of Biochemistry, Microbiology and Pha
The human metapneumovirus, more simply referred to
Indegene, a digital-first life sciences commercial
Alembic Pharmaceuticals Limited (Alembic) announce
'Simplicity' seems to be the perfect word to descr
Dear Readers, Welcome to the latest issue of The Magazine
The trial may start from Wednesday, said a top official of the institute, among the 17 sites selected for the phase two human trials in the nation by Serum Institute of India (SII).
“To begin with we’ve identified five volunteers who will undergo COVID-19 and antibodies test. Those whose reports are negative will be shortlisted for vaccination on Wednesday,” said Dr Sanjay Lalwani, Medical Director, Bharti Vidyapeeth’s Medical College and Hospital and Research Centre.
He said the hospital was given a target of enlisting 300 to 350 volunteers. Those selected for getting a dose of vaccine will probably be from the age group of 18 to 99 years, ” he told PTI.
Dr Jeetendra Oswal, deputy medical director of the hospital,” said after they are administered the vaccine, the volunteers will be monitored in accordance with the standard trial protocol.
The other associations in which trials are to be conducted include B J Medical College Hospital in Pune, AIIMS Delhi, Rajendra MemorialResearch Institute of Medical Sciences in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh,Nehru Hospital in Gorakhpur and Andhra Medical College at Visakhapatnam.
SII, the world’s largest vaccine maker, has signed an agreement to manufacture the possible vaccine developed by the Jenner Institute of Oxford University in cooperation with British-Swedish pharma company AstraZeneca.
